Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2010
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010US7811572 preparing a cell-binding agent chemically coupled to a drug; covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step; high purity and stability
10/12/2010US7811571 Binding polyallylamine with signal molecules having a functional group, purification, binding the purified protein, antibody, antigen nucleic acid capture agents to form a conjugate
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010US7811569 Recombinant anti-Plasmodium falciparum antibodies
10/12/2010US7811567 Methods of using antibodies against human IL-22
10/12/2010US7811566 Antibody-induced apoptosis
10/12/2010US7811564 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA)
10/12/2010US7811563 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases
10/12/2010US7811562 identifying patients whose cancers are likely to be responsive to IGF1R (Insulin-like Growth Factor 1 Receptor) inhibitory anti-cancer therapy; treating a non-small cell lung tumor, an ovarian tumor, a neuroblastoma tumor or an osteosarcoma tumor in a mammalian
10/12/2010US7811561 MCT-1, a human oncogene
10/12/2010CA2616344C A method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response
10/12/2010CA2513352C Canine vaccines against bordetella bronchiseptica
10/12/2010CA2497287C Method of humanizing immune system molecules
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2341268C Streptococcus suis vaccines and diagnostic tests
10/12/2010CA2339034C Process for purifying human papillomavirus virus-like particles
10/12/2010CA2336114C Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
10/12/2010CA2327528C Recombinant virus expressing foreign dna encoding feline cd80, feline ctla-4 or feline cd86 and uses thereof
10/12/2010CA2308765C The use of an ox-2 protein or nucleic acid in immunomodulation
10/12/2010CA2229590C Pharmaceutical composition containing inhibitors of interferon- gamma
10/12/2010CA2219943C Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
10/12/2010CA2198586C Mutant enterotoxin effective as a non-toxic oral adjuvant
10/12/2010CA2196570C Recombinant herpesvirus of turkeys and uses thereof
10/07/2010WO2010115172A2 Antigenic peptide of hsv-2 and methods for using same
10/07/2010WO2010115118A2 Methods for preparing and using multichaperone-antigen complexes
10/07/2010WO2010115092A2 Compositions and methods for treating or preventing inflammatory bowel disease and colon cancer
10/07/2010WO2010115046A2 Vaccine compositions and methods of use thereof
10/07/2010WO2010114940A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010WO2010114930A1 Methods of use for hsv-1 and hsv-2 vaccines
10/07/2010WO2010114860A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010WO2010114859A1 Treatment of insulin-resistant disorders
10/07/2010WO2010114833A1 Methods for treating diseases using a bone morphogenetic protein
10/07/2010WO2010114629A2 Formulation
10/07/2010WO2010114312A2 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
10/07/2010WO2010114169A1 Method for prophylaxis of influenza using vaccine for intranasal administration
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113495A1 C6orf167 peptides and vaccines containing the same
10/07/2010WO2010113148A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation
10/07/2010WO2010113117A2 Preparation of isolated agonist anti-edar monoclonal antibodies
10/07/2010WO2010112962A1 Identification, optimization and use of cryptic hla-a24 epitopes for immunotherapy
10/07/2010WO2010112935A1 Diagnostic test for virus
10/07/2010WO2010112656A1 Compounds stimulating undesirable cellular adhesion and applications thereof
10/07/2010WO2010112569A1 Modulation of adipose triglyceride lipase for prevention and treatment of cachexia, loss of weight and muscle atrophy and methods of screening therefor
10/07/2010WO2010112458A1 Composition and methods of use for therapeutic antibodies specific for the il-12 receptore betal subunit
10/07/2010WO2010112413A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan
10/07/2010WO2010112110A1 Anti-icam-1 antibody, uses and methods
10/07/2010WO2010111842A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/07/2010WO2010111792A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses
10/07/2010WO2010111746A1 Anti-vegf-d antibodies
10/07/2010WO2010093537A3 Influenza hemagglutinin and neuraminidase variants
10/07/2010WO2010086828A3 Agonist anti-trkb monoclonal antibodies
10/07/2010WO2010085162A3 Expression cassettes, T-DNA molecules, plant expression vectors, transgenic plant cells as well as the use thereof in the production of a vaccine
10/07/2010WO2010079510A3 Anti-rhd monoclonal antibodies
10/07/2010WO2010077986A3 Production of influenza vaccines
10/07/2010WO2010075861A3 Methods of identifying critically ill patients at increased risk of development of organ failure and compounds for the treatment hereof
10/07/2010WO2010075249A3 A method for treating rheumatoid arthritis with b-cell antagonists
10/07/2010WO2010070052A3 Immunogenic polypeptides comprising a scaffold polypeptide and a l2 polypeptide or a fragment thereof
10/07/2010WO2010065578A3 POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
10/07/2010WO2009130618A3 Flagellin polypeptide vaccines
10/07/2010WO2008140414A8 Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
10/07/2010US20100256068 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
10/07/2010US20100255579 Tumor antigen protein and use thereof
10/07/2010US20100255538 Antibodies to insulin-like growth factor i receptor
10/07/2010US20100255501 Method of identifying a mhc class i restricted t cell response
10/07/2010US20100255108 Combination Treatment of Cancer With Cetuximab and Tetrac
10/07/2010US20100255087 oral pharmaceutical composition
10/07/2010US20100255081 Method for treating symptoms of diabetes
10/07/2010US20100255074 Transmembrane prostatic acid phosphatase
10/07/2010US20100255061 Posterior Segment Drug Delivery
10/07/2010US20100255057 Device for actively removing a target cell from blood or lymph of a vertebrate subject
10/07/2010US20100255043 Methods for preparing T-cells for cell therapy
10/07/2010US20100255040 Composition for improving tlr-mediated cellular immunity comprising poly-gamma-glutamic acid
10/07/2010US20100255039 Induction of tolerance to egg proteins
10/07/2010US20100255038 Purified polypeptide comprising or consisting of a c-terminus msp1 antigen from plasmodium falciparum carrying a glycosyl-phosphatidyl-inositol group (gpi)
10/07/2010US20100255037 Novel sequences of haemonchus contortus, immunogenic compositions, methods for preparation and use thereof
10/07/2010US20100255036 Attenuated fnr deficient enterobacteria
10/07/2010US20100255035 Modified live (JMSO strain) Haemophilus parasuis vaccine
10/07/2010US20100255034 Streptococcus Pyogenes Antigens
10/07/2010US20100255033 Non-toxic double mutant forms of pertussis toxin as adjuvants
10/07/2010US20100255032 Parapoxviruses in combination with other antiviral agents for the treatment of viral diseases
10/07/2010US20100255031 truncated l1 protein of human papillomavirus type 16
10/07/2010US20100255030 Avirulent, immunogenic flavivirus chimeras
10/07/2010US20100255029 Newcastle disease virus vectored avian vaccines
10/07/2010US20100255028 Flavivirus Vaccine Vector Against Influenza Virus
10/07/2010US20100255027 Papilloma pseudovirus and preparation
10/07/2010US20100255026 Methods and compositions relating to anthrax spore glycoproteins as vaccines
10/07/2010US20100255023 Dendritic cell vaccine compositions and uses of same
10/07/2010US20100255022 Vaccine against clostridium perfringens
10/07/2010US20100255021 Truncated l1 protein of human papillomavirus type 6
10/07/2010US20100255020 Method for inducing cytotoxic t-cells, cytotoxic t-cell inducers, and pharmaceutical compositions and vaccines employing them
10/07/2010US20100255019 Ii-KEY/HER-2/NEU HYBRID CANCER VACCINE
10/07/2010US20100255018 Polynucleotides and polypeptides involved in gestational malaria, and biological applications
10/07/2010US20100255017 Purified hemocyanin obtained from fissurella latimarginata, fissurella cumingi or fissurella maxima; subunit of purified hemocyanin; use of hemocyanin, its subunit or immunogenic fragments and compositions containing the same
10/07/2010US20100255016 Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
10/07/2010US20100255015 Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosis
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100255012 Recombinant fucose modified monovalent half-antibodies obtained by molecular engineering
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 1823